Please select the outcome measures that correspond to the clinical trial below.
Title: Time Restricted Feeding for Weight Loss and Cardio-protection
Brief Summary: Time restricted feeding (TRF) is a novel form of intermittent fasting that involves confining the period of food intake to 8 h/d (e.g. 10 am to 6 pm) without calorie counting. TRF is effective for weight loss and cardio-protection in obese adults. It is of great interest to see whether subjects can adhere to TRF for longer periods of time, and to see what degree of weight loss that can be achieved with TRF. Accordingly, the aims of this trial are: Aim 1: To determine if TRF can be implemented to facilitate weight loss in obese adults, and Aim 2: To determine if TRF can produce clinically meaningful reductions in plasma lipids, blood pressure, insulin resistance, and inflammatory markers.


Options:
A: Change From Baseline in Participant Glucose When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Human Growth Hormone (HGH) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Insulin When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Glycogen-Like Protein-1 (GLP-1) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Adiponectin When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Fibroblast Growth Factor-21 (FGF-21) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant White Blood Cell Count (WBC) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Hemoglobin When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Red Blood Cell Count (RBC) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Hematocrit When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Platelet Count When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Mean Corpuscular Volume (MCV) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Mean Corpuscular Hemoglobin (MCH) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Mean Corpuscular Hemoglobin Concentration (MCHC) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Red Cell Distribution Width (RDW) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Mean Platelet Volume (MPV) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Bicarbonate When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Sodium When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Chloride When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Blood Urea Nitrogen (BUN) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Calcium When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Potassium When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Creatinine When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Total Cholesterol (TC) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Low-Density Lipoprotein Cholesterol (LDL-C) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant High-Density Lipoprotein Cholesterol (HDL-C) When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Triglycerides When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant TC/HDL Ratio When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Weight When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Waist Circumference When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Systolic Blood Pressure (SBP), Supine When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant Diastolic Blood Pressure (DBP), Supine When Fasting and Fed (Baseline and 3 days); Change From Baseline in Participant High Sensitivity C-Reactive Protein (hsCRP) When Fasting and Fed (Baseline and 3 days)
B: Adipose tissue dynamics (12 weeks)
C: Body weight (12 weeks)
D: Fat mass (8 weeks); Fat-free mass (8 weeks); Body fat percentage (8 weeks); Upper body muscle hypertrophy (8 weeks); Lower body muscle hypertrophy (8 weeks)

Answer: C